Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

Heather L. Sings(Pfizer (United States)), Luis Jódar(Pfizer (United States)), Philippe De Wals(Université Laval), Jose A Suaya(Pfizer (United States)), Bradford D. Gessner(Pfizer (United States)), Craig A. Laferrière(Pfizer (Canada)), John M. McLaughlin(Pfizer (United States)), Raúl Istúriz(Pfizer (United States)), Heinz‐Josef Schmitt(Pfizer (France)), Stephen I. Pelton(Boston Medical Center)
Clinical Infectious Diseases
October 22, 2018
10.1093/cid/ciy920
Cited by 117

Related Papers

The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|The Lancet|2017|2.4k
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
|The Lancet|2021|1.7k
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
|The Lancet|2021|1.3k
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
|The Lancet|2011|999